Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
about
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease.Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation.Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
P2860
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@ast
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@en
type
label
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@ast
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@en
prefLabel
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@ast
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@en
P2093
P2860
P356
P1476
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704040
P407
P577
2003-06-01T00:00:00Z
P5875
P6179
1006548576